State Ledger
Company profile

Elanco Animal Health Inc CIK 1739104

Ticker
ELAN (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Indianapolis, IN 46221
Fiscal year end
2025 (FY)
Market Data
Close
$22.57
Change
-$0.35
Change %
-1.51%
Volume
313,057

ELAN · trading date Oct 12, 2026 · previous close $22.92 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$4.72B
Net income
-$232.00M
Total assets
$13.36B
Total liabilities
$6.81B
Stockholders' equity
$6.55B
Cash & equivalents
$545.00M
Operating income
—
Operating cash flow
$560.00M
Capital expenditures
$276.00M

Fiscal year 2025, via 10-K filed 2026-02-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
-4.9%
Free cash flow
$284.00M
Free cash flow margin
6.0%
Liabilities / assets
51.0%
Equity / assets
49.0%
CapEx / revenue
5.9%
Operating cash flow / net income
-2.41×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $4.72B -$232.00M $13.36B $6.81B $6.55B
2024 $4.44B $338.00M $12.61B $6.52B $6.10B
2023 $4.42B -$1.23B $14.36B $8.14B $6.22B
2022 $4.41B -$78.00M $15.49B $8.20B $7.29B
2021 $4.76B -$483.00M $16.48B $8.97B $7.51B
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-09
Financials filed via
Form 10-K
filed 2026-02-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Indianapolis, IN 46221
450 ELANCO CIRCLE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:31 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Indiana — Public Companies